DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



One Hour Preoperative Gatifloxacin

Information source: Stanford University
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Ophthalmic Surgery

Intervention: Zymar (Drug)

Phase: Phase 4

Status: Completed

Sponsored by: Stanford University

Official(s) and/or principal investigator(s):
Christopher Ta, MD, Principal Investigator, Affiliation: Stanford University

Summary

Comparison of 1 day versus 1 hour application of topical Zymar.

Clinical Details

Official title: One Hour Preoperative Gatifloxacin

Study design: Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Investigator), Primary Purpose: Prevention

Primary outcome: Number of Participant With Positive Culture

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- ophthalmic surgery

Exclusion Criteria:

- taken antibiotics, allergic to fluoroquinolones

Locations and Contacts

Stanford, Stanford, California 94304, United States
Additional Information

Starting date: January 2007
Last updated: January 26, 2015

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017